Best International Stocks For 2015

SAO PAULO–Brazilian equities are cheap compared to other markets around the world after the country�� stock market posted one of the worst performances anywhere in 2013. Yet that doesn�� necessarily mean it�� time to buy.

Agence France-Presse/Getty Images

��he problem is cheap is great, but there just doesn�� appear to be a catalyst for a rebound in the market,��says Michelle Gibley Director of International Research at Charles Schwab(SCHW).

Ms. Gibley says she�� been pessimistic on Brazil for quite some time, as the country is caught in a negative growth spiral. High inflation means the central bank has to raise interest rates, which will slow growth further. A weakening currency and strong public spending compound the problems.

Best International Stocks For 2015: Callidus Software Inc.(CALD)

Callidus Software Inc., together with its subsidiaries, provides sales performance management (SPM) software applications and services. Its products include TrueComp Manager application that automates the modeling, design, administration, reporting, and analysis of pay-for-performance programs; Callidus Reporting for delivering real-time production reports; Callidus Analytics, which enable businesses to deploy performance dashboards across the finance, sales executive, and sales force teams; Callidus Objective Management to design and deploy strategic objective-based bonus plans and long term incentive programs; and Callidus Quota Management to allocate quotas effectively. The company?s products also comprise Callidus Communicator, which accelerates and streamlines communications with a business sales force and sales channels; Callidus Channel Management for telecommunication companies to view and update dealer information; Callidus Producer Management for insurance carri ers; Callidus Onboarding to build and optimize discrete, re-usable workflows; Callidus Coaching to optimize performance of their sales force and call centers; Callidus Plan Communicator that accelerates the process of rolling out and communicating incentive plans across the sales force; Callidus Commissions Manager for sales professionals; and ACom3, an incentive compensation automation suite. In addition, it provides software consulting services, including a range of SPM solution implementations, system upgrades, compensation plan enhancements, migration assistance, reporting and integration consulting, and solution architecture services; and SaaS-based sales assessments, coaching, and talent development solutions. The company serves the telecommunications, insurance, banking, technology, and life sciences/pharmaceuticals markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Callidus Software was founded in 1996 and is headquartered in Pleasanton, California.

Advisors' Opinion:

• [By James Oberweis]

  Callidus Software (CALD) is a leading software-as-a-service provider of sales force effectiveness solutions, with more than 1,700 customers.

  Its products help align sales reps' goals with the firm's goals. Since the beginning of 2011, Callidus has dramatically expanded its product offering through the completion of eight acquisitions.

Best International Stocks For 2015: BioCryst Pharmaceuticals Inc.(BCRX)

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer, and inflammatory diseases. It uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry, and computer to develop new therapeutic candidates. The company has three novel late-stage compounds in development, which include Peramivir, a neuraminidase inhibitor for the potential treatment of influenza; BCX4208, a purine nucleoside phosphorylase (PNP) inhibitor for gout; and Forodesine, a PNP inhibitor for cutaneous T-cell lymphoma (CTCL) and chronic lymphocytic leukemia (CLL). Peramivir is being developed under a contract from the Biomedical Advanced Research and Development Authority within the United States Department of Health and Human Services. Forodesine has been granted orphan drug status by the FDA for thr ee indications, which include T-cell non-Hodgkin?s lymphoma, including CTCL; CLL and related leukemias, including T-cell prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for treatment of B-ALL. The FDA has also granted fast track status to the development of forodesine for the treatment of relapsed or refractory T-cell leukemia, and special protocol assessment from the FDA for forodesine to conduct a pivotal clinical trial in CTCL with an oral formulation. The company announced the initiation of a Phase 2b study of BCX4208 as add-on therapy in gout patients who have not responded to allopurinol therapy alone. BioCryst Pharmaceuticals utilizes crystallography and structure-based drug design to discover additional compounds and to progress others through pre-clinical and early development to address the unmet medical needs of patients and physicians. The company was founded in 1986 and is headquartered in Durham, North Carolina.

Advisors' Opinion:

• [By Monica Gerson]

  BioCryst Pharmaceuticals (NASDAQ: BCRX) shares gained 5.98% to $6.91 in the pre-market session after the company has been awarded contract by the National Institute of Allergy and Infectious Diseases to develop BCX4430 for the treatment of Marburg virus disease.

Hot Casino Stocks To Buy Right Now: Envision Healthcare Holdings Inc (EVHC)

Envision Healthcare Holdings, Inc., incorporated on February 28, 2011, is a provider of physician-led, outsourced medical services in the United States. The Company offers a range of clinically-based and coordinated care solutions across the patient continuum from medical transportation to hospital encounters to comprehensive care alternatives in various settings. The Company conduts its business primarily through two operating subsidiaries, EmCare Holdings, Inc. (EmCare) and American Medical Response, Inc. (AMR). The Company markets its services primarily under the EmCare and AMR brands. EmCareis a provider of integrated facility-based physician services, including emergency, anesthesiology, hospitalist/inpatient care, radiology, tele-radiology and surgery. EmCare also offers physician-led care management solutions outside the hospital. AMR is a provider and manager of community-based medical transportation services, including emergency (911), non-emergency, managed transportation, fixed-wing air ambulance and disaster response.

EmCare is a provider of integrated facility-based physician services to healthcare facilities, communities and payors in the United States. During the year ended December 31, 2012 (fiscal 2012), EmCare had approximately 10.5 million weighted patient encounters in 44 states and the District of Columbia. The Company segregates patient encounters into four categories:ED visits, hospitalist encounters, radiology reads and anesthesiology cases due to the differences in reimbursement rates for and associated costs of providing the various services. In fiscal 2012, AMR treated and transported approximately 2.8 million patients in 40 states and the District of Columbia. As of December 31, 2012, AMR had more than 3,700 contracts with communities, government agencies, healthcare providers and insurers to provide ambulance transport services. The Company segregates transports into two categories: ambulance transports (including emergency, as well as non-emergency, critical! care and other interfacility transports) and wheelchair transports to the differences in reimbursement rates for and associated costs of providing ambulance and wheelchair transports.

The Company competes with Team Health, Hospital Physician Partners, The Schumacher Group, Sheridan Healthcare, California Emergency Physicians, National Emergency Services Healthcare Group, IPC, Rural/Metro Corporation, Falck, Southwest Ambulance, Paramedics Plus and Acadian Ambulance.

Advisors' Opinion:

• [By John Kell]

  Envision Healthcare Holdings Inc.(EVHC) lowered its 2013 earnings outlook but also projected an adjusted profit for the recently started new year that topped expectations. The company said results improved in the latter part of the quarter, mostly the result of higher flu-related activity and seasonal volume. Shares rose 6.3% to $34.60 premarket.

Best International Stocks For 2015: Hospira Inc (HSP)

Hospira, Inc. (Hospira), incorporated on September 16, 2003, is a provider of injectable drugs and infusion technologies. Hospira's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products. Hospira's portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. Hospira conducts operations worldwide and is managed in three reportable segments: Americas; Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment includes the United States, Canada and Latin America; the EMEA segment includes Europe, the Middle East and Africa, and the APAC segment includes Asia, Japan, Australia and New Zealand. In all segments, Hospira sells a line of products, including specialty injectable and other pharmaceuticals and medication management products.

Specialty Injectable Pharmaceuticals

Hospira's specialty injectable pharmaceutical products consist of generic injectable pharmaceuticals. The other drugs' therapeutic areas include analgesia, anesthesia, anti-infectives, cardiovascular, oncology, and other areas. All of Hospira's generic injectable pharmaceuticals in the United States include unit-of-use bar-code labels that can be used to support medication delivery. Hospira primarily procures the active pharmaceutical ingredients in these products from third-party suppliers. During the year ended December 31, 2011, Hospira portfolio included 87 injectable drug launches consisting of 13 compounds. Among these launches included, in the United States, docetaxel (an oncolytic drug used to treat a variety of cancers), topotecan (an oncolytic drug used for the treatment of small cell lung cancer) and imipenem-cilastatin (a beta-lactam antibiotic). Hospira also launched a solution formulation of gemcitabine (an oncolytic drug used to treat a variety of cancers), which augmented Hospira's portfolio of gemcitabin! e products. New-to-country launches in EMEA in 2011, included topotecan, meropenem, gemcitabine, imipenem-cilastatin, remifentanil, docetaxel and levofloxacin. New-to-country launches in APAC in 2011, included docetaxel, piperacillin tazobactam, oxaliplatin, meropenem and gemcitabine. Hospira's specialty injectable pharmaceutical products also include Precedex (dexmedetomidine HCl), a sedative. Precedex is licensed to Hospira by Orion Corporation in the Americas and APAC segments, and in the Middle East and Africa.

Hospira sells and markets Precedex for use in non-intubated patients requiring sedation, as well as intubated and mechanically ventilated patients. Hospira's specialty injectable pharmaceuticals also include biologic products, which are molecules derived from cells that are demonstrated to be similar to an approved originator product. Hospira's biosimilar, Retacrit, was available in 20 EMEA countries during 2011. Its second biosimilar, Nivestim, was launched during the year ended December 31, 2010, and was available in 21 countries, including Australia, where the biosimilar filgrastim product was launched in 2011. Hospira's drug delivery formats include offerings in ampules and flip-top vials, which clinicians can use with standard syringes. Hospira's drug delivery options include Carpuject and iSecure prefilled syringes, AnsyrTM prefilled needleless emergency syringe systems, First Choice ready-to-use premix and the ADD-Vantage system for preparing drug solutions from prepackaged drug powders or concentrates.

Other Pharmaceuticals

Hospira's other pharmaceuticals primarily consist of intravenous (I.V.) solutions, nutritionals and contract manufacturing services. Hospira offers infusion therapy solutions and related supplies that include I.V. solutions for general use, I.V. nutrition products, and solutions for the washing and cleansing of wounds or surgical sites. All of Hospira's injectable I.V. solutions in the United States include unit-of-use bar-c! ode label! s that can be used to support medication management efforts. Hospira also offers infusion therapy solutions in its VisIV non-PVC, non-DEHP I.V. container, an I.V. bag. Hospira's contract manufacturing services are offered through its One2One services group, which provides formulation development, filling and finishing of injectable and oral drugs worldwide. Hospira works with its pharmaceutical and biotechnology customers to develop injectable forms of their drugs, and Hospira fills and finishes those and other drugs into containers and packaging selected by the customer. The customer then sells the finished products under its own label. Hospira's One2One manufacturing services group generally does not manufacture active pharmaceutical ingredients, but offers a range of filling and finishing services in a variety of delivery systems.

Medication Management

Medication management products include electronic drug delivery pumps, safety software and disposable administration sets dedicated to Hospira pumps. These sets are used to deliver I.V. fluids and medications. Hospira also offers software maintenance agreements and other service offerings. Hospira's electronic drug delivery pumps include Hospira's general infusion system, Symbiq; the Plum A+ line of infusion pumps; Hospira's patient-controlled analgesia device, LifeCare PCA; the GemStar ambulatory infusion pump; and the Plum XLD infusion pump. Hospira offers the Hospira MedNet safety software system, which has been designed to enable hospitals to customize intravenous drug dosage limits and track drug delivery to prevent medication errors. The wireless network version of the Hospira MedNet system establishes real-time send-and-receive capability and can interface with select hospital and pharmacy information systems. The Hospira MedNet system is standard in the Symbiq infusion system, and is also available as an additional feature for the Plum A+ line, and LifeCare PCA devices. Hospira also offers safety software with its Ge! mStar pum! p.

Medication management includes TheraDoc, Inc. products, which are module-based clinical surveillance systems that provide patient safety surveillance and clinical decision support. Medication management also includes gravity administration sets and other device products, including needlestick safety products and programs to support Hospira's customers' needlestick prevention initiatives. LifeShield CLAVE and LifeShield MicroCLAVE connectors are one-piece valves that directly connect syringes filled with medications to a patient's I.V. line without the use of needles. ICU Medical's CLAVE connectors are a component of administration sets sold by Hospira to its customers in the United States and select markets outside the United States.

The Company competes with Baxter International Inc., Boehringer Ingelheim, Fresenius Kabi, Pfizer, Sandoz, Sanofi, Teva Pharmaceuticals, B. Braun Melsungen AG, CareFusion, Terumo, Actavis, Intas Pharmaceuticals, Ltd, Medac GmbH, Mylan Inc., Sun Pharmaceutical Industries, Ltd. and Aspen.

Advisors' Opinion:

• [By Sean Williams]

  And finally, would you be shocked if I said that medical-device and drug maker Hospira (NYSE: HSP  ) ended the week on a high following a positive opinion from the CHMP on its biosimilar drug known as inflectra? The drug, which is targeted at treating rheumatoid arthritis, inflammatory bowel diseases, and plaque psoriasis, is a biosimilar of Johnson & Johnson's�blockbuster Remicade, which generates $6 billion in annual sales. Assuming Hospira can gain approval for inflectra (which appears likely, since the EMA often follows the advice of its panel), it could garner a big chunk of J&J's sales in the EU.

• [By Jonas Elmerraji]

  Pharmaceutical firm Hospira (HSP) hasn't done much since July; shares have been trading sideways for months now. But even though Hospira hasn't really participated in the recent rally, there's still a trade to be made here.

  Hospira is currently forming a rectangle pattern, a price setup that's formed by a horizontal resistance level above shares at $42 and another horizontal support level down at $38.50. The rectangle gets its name because it essentially "boxes in" shares. The high-probability trade comes when HSP exits its channel -- a move through $42 is a buy signal, whereas a drop below $38.50 is a signal to sell.

  Whenever you're looking at any technical price pattern, it's critical to think in terms of those buyers and sellers. Rectangles, triangles, and other pattern names are a good quick way to explain what's going on in a stock, but they're not the reason it's tradable. Instead, it all comes down to supply and demand for shares.

  That $42 resistance level, for example, is a price where there has been an excess of supply of shares; in other words, it's a place where sellers have been more eager to step in and take gains than buyers have been to buy. That's what makes a breakout above it so significant -- the move means that buyers are finally strong enough to absorb all of the excess supply above that price level.

  Sit on the sidelines until HSP breaks outside of the rectangle.

Best International Stocks For 2015: USANA Health Sciences Inc.(USNA)

USANA Health Sciences, Inc. develops, manufactures, distributes, and sells nutritional and personal care products worldwide. It offers the USANA Nutritionals product line, which consists of essentials, which include vitamin and mineral supplements that provide a foundation of nutrition for various age groups; optimizers that are targeted supplements supporting needs, such as cardiovascular health, skeletal/structural health, and digestive health; and foods comprising low-glycemic meal replacement shakes, snack bars, and other related products that offer optimal macro-nutrition. Its Sense product line comprises personal care products that support healthy skin and hair. The company also offers materials and online tools, such as associate starter kit and product brochures that are designed to assist associates in building their businesses and in marketing our products. USANA Health Sciences, Inc. primarily distributes its products through a network marketing system of indepe ndent distributors. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.

Advisors' Opinion:

• [By James E. Brumley]

  Two years and two weeks later - with a triple digit gain under my belt - I'm saying goodbye to USANA Health Sciences, Inc. (NYSE:USNA). My hypothetical portfolio of stocks that I like and want to play with as a trade in my 'sandbox' portfolio (a model portfolio I've admittedly ignored too much) added USNA back on July 8th of 2010. Now, up 119%, I'm pulling the plug on the position.

• [By Ben Levisohn]

  Shares of Herbalife have jumped 4.2% to $71.81 in after-hours trading after gaining 3.8% today. Herbalife, Nu Skin Enterprises (NUS) and Usana Health Sciences�(USNA) advanced today on reports that China was considering stricter regulation of multi-level sellers.

Best International Stocks For 2015: Portugal Telecom SGPS S.A .(PT)

Portugal Telecom, SGPS, S.A., together with its subsidiaries, provides telecommunications services in Portugal, Brazil, sub-Saharan Africa, and Asia. It offers fixed line telephone, Internet protocol television, and direct-to-home satellite pay-TV services; and mobile telecommunications services, such as voice, data, and Internet-related multi-media services primarily for mobile phones, smart phones, tablets, and laptops. The company also provides enterprise services, including data and business solutions, as well as information technology/information system and business process outsourcing services. In addition, it provides engineering solutions and training services in telecommunications; postal network services; consultant negotiation services; public telecommunication services and telebroadcasting services; call center services; mobile cellular services; and development and consultancy services in the areas of electronic commerce, contents, telecommunications, and info rmation technology. Further, it engages in the purchase, management, administration, sale, and investment consultancy of real estate properties; business advisory board service installment, consultation, administration, and business management; and pension fund management,. Additionally, the company provides wholesale services comprising leased lines, interconnection, unbundled access to its local loops, broadband asymmetric digital subscriber line (ADSL), wholesale line rental, access to ducts, transmission of television and radio signals, and international carrier services. The company also publishes directories; provides portal services; and sells telecommunications equipment. As of December 31, 2010, it had approximately 4.9 million telephone and ADSL access lines in service. The company was formerly known as Portugal Telecom, SA and changed its name to Portugal Telecom, SGPS, S.A. in December 2000. Portugal Telecom, SGPS, S.A. was founded in 1994 and is based in Lisbon, Portugal.

Advisors' Opinion:

• [By John Buckingham]

  We have been positive on Portugal Telecom (PT) and its domestic turnaround, as well as its 25% ownership stake in Brazilian telecom provider Grupo Oi, for some time.

• [By Brian Pacampara]

  Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, telecommunications company Portugal Telecom (NYSE: PT  ) has earned a coveted five-star ranking.

Best International Stocks For 2015: UIL Holdings Corp (UIL)

UIL Holdings Corporation, incorporated on March 22, 1999, is engaged in the ownership of its operating regulated utility businesses. The utility businesses consist of the electric distribution and transmission operations of The United Illuminating Company (UI) and the natural gas transportation, distribution and sales operations of The Southern Connecticut Gas Company (SCG), Connecticut Natural Gas Corporation (CNG), and The Berkshire Gas Company (Berkshire, and together with SCG and CNG, the Gas Companies). The Company operates in Electric Distribution, Electric Transmission and Gas Distribution segments.

UI is an electric distribution and transmission utility. UI is also a party to a joint venture with certain affiliates of NRG Energy, Inc. (NRG affiliates) pursuant to which UI holds 50% of interests in GCE Holding LLC, whose wholly owned subsidiary, GenConn Energy LLC operates generation plants in Devon, Connecticut (GenConn Devon) and Middletown, Connecticut (GenConn Middletown).

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Utilities sector was the only decliner in the US market today. Top losers in the sector included UIL Holdings (NYSE: UIL), off 2.1 percent, and Crosstex Energy (NASDAQ: XTXI), down 2.2 percent.

Best International Stocks For 2015: Cott Corp (COT)

Cott Corporation (Cott), incorporated on December 31, 2006, is a producers of beverages on behalf of retailers, brand owners and distributors. The Company�� product lines include carbonated soft drinks (CSDs), 100% shelf stable juice and juice-based products, clear, still and sparkling flavored waters, energy products, sports products, new age beverages, and ready-to-drink teas, as well as alcoholic beverages for brand owners. The Company operates in five segments: North America (which includes the United States operating segment and Canada operating segment), the United Kingdom (which includes its United Kingdom reporting unit and its Continental European reporting unit), Mexico, Royal Crown International (RCI) and All Other. The Company markets or supplies over 500 retailer, licensed and Company-owned brands in its four core geographic segments. In March of 2012, its U.K. reporting segment acquired a beverage and wholesale business based in Scotland.

Advisors' Opinion:

• [By Lee Jackson]

  Cott Corp. (NYSE: COT) stock has pulled back some 30% from its 52-week high of $11.25 after second-quarter market conditions were presented as “challenging.” However, the dividend was reinstated after a ten-year hiatus, and the company bought back $6 million worth of shares in the second quarter. The company mainly does business in the United States, the United Kingdom, Canada and Mexico, but it also sells beverage concentrate to 50 other countries. Deutsche Bank rates Cott as a stock to buy and has an $11 price target. The consensus is posted at $10. Investors are paid a decent 2.9% dividend. The Friday close for Cott was $7.87.

• [By Dan Caplinger]

  But SodaStream is continuing to pull out all stops in order to improve its results. SodaStream's recent partnership with Samsung to incorporate carbonation technology into high-end refrigerators could help drive growth for consumers who don't want to deal with a separate appliance in their kitchens. Moreover, SodaStream's deal in March with bottler Cott (NYSE: COT  ) to produce soda syrup within the U.S. should help it boost its efficiency in getting flavors to domestic customers.

• [By Roberto Pedone]

  Cott (COT) is engaged in the production of beverages on behalf of retailers and distributors. This stock closed up 4.5% to $8.75 a share in Thursday's trading session.

  Thursday's Range: $8.29-$8.84
  
  52-Week Range: $7.24-$11.25
  
  Thursday's Volume: 1.82 million
  
  Three-Month Average Volume: 466,884

  From a technical perspective, COT jumped higher here right above its 50-day moving average of $8.14 with monster upside volume. This stock has been uptrending strong for the last month and change, with shares moving higher from its low of $7.39 to its intraday high of $8.84. During that move, shares of COT have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of COT within range of triggering a major breakout trade. That trade will hit if COT manages to take out some near-term overhead resistance levels at $8.84 to $9 with high volume.

  Traders should now look for long-biased trades in COT as long as it's trending above its 50-day at $8.14 and then once it sustains a move or close above those breakout levels with volume that hits near or above 466,884 shares. If that breakout hits soon, then COT will set up to re-test or possibly take out its next major overhead resistance levels at $9.50 to 10.25. Any high-volume move above $10.25 will then give COT a chance to re-fill its previous gap-down zone from May that stared near $11.

Best International Stocks For 2015: Universal Technical Institute Inc(UTI)

Universal Technical Institute, Inc. engages in the provision of postsecondary education for students seeking careers as professional automotive, diesel, collision repair, motorcycle, and marine technicians in the United States. It offers undergraduate degree, diploma, and certificate programs through its campuses under various brands, including Universal Technical Institute, Motorcycle Mechanics Institute and Marine Mechanics Institute, and NASCAR Technical Institute. The company also provides manufacturer-specific training programs comprising student paid electives at its campuses and manufacturer or dealer sponsored training at certain campuses and dedicated training centers. Universal Technical Institute, Inc. was founded in 1965 and is headquartered in Scottsdale, Arizona.

Advisors' Opinion:

• [By Laura Brodbeck]

  Tuesday

  Earnings Expected From: Bank of Montreal (NYSE: BMO), United Natural Foods, Inc. (NASDAQ: UNFI), OmniVision Technology, Inc. (NASDAQ: OVTI), Universal Technical Institute, Inc. (NYSE: UTI) Economic Releases Expected: Chinese HSBC Services PMI, Australian GDP, Brazilian GDP, eurozone PPI, British construction PMI.

  Wednesday

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Universal Technical Institute (NYSE: UTI  ) , whose recent revenue and earnings are plotted below.

Best International Stocks For 2015: Centene Corporation (CNC)

Centene Corporation provides multi-line healthcare programs and services in the United States. It operates in two segments, Medicaid Managed Care and Specialty Services. The Medicaid Managed Care segment provides Medicaid and Medicaid-related health plan coverage to individuals through government subsidized programs, including Medicaid, the State children�s health insurance program, long-term care, foster care, and Medicare special needs plans, as well as aged, blind, or disabled programs. Its health plans provide primary and specialty physician care, inpatient and outpatient hospital care, transportation assistance, emergency and urgent care, vision care, prenatal care, dental care, laboratory and x-ray services, immunizations, prescriptions and over-the-counter drugs, home health and durable medical equipment, behavioral health and substance abuse services, therapies, social work services, care coordination, and 24-hour nurse advice line. The Specialty Services segment manages behavioral healthcare for members; provides health insurance to individual customers and their families; implements life and health management programs; offers long-term care services to the elderly and people with disabilities; and administers routine and medical surgical eye care benefits through its network of eye care providers. It also offers telehealth services; and claims processing, pharmacy network management, benefit design consultation, drug utilization review, formulary and rebate management, specialty and mail order pharmacy services, and patient and physician intervention services, as well as provides care management solutions that automate the clinical, administrative, and technical components of care management programs. The company offers its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.

Advisors' Opinion:

• [By Monica Gerson]

  Breaking news

  Whirlpool (NYSE: WHR) reported a strong rise in its third-quarter earnings. For the year, Whirlpool lifted its earnings forecast to $9.90 to $10.10 per share, versus its July outlook of $9.50 to $10 per share. To read the full news, click here. Questcor Pharmaceuticals (NASDAQ: QCOR) announced today that it will commence a Phase 2 study to explore the efficacy and safety of H.P. Acthar庐 Gel (repository corticotropin injection) for Acute Respiratory Distress Syndrome (ARDS). To read the full news, click here. Centene (NYSE: CNC) reported a stronger-than-expected third-quarter profit. Centene's quarterly net earnings surged to $49.4 million, or $0.87 per share, up from $3.8 million, or $0.07 per share, in the year-ago period. To read the full news, click here. Dwolla and Alliance Data Systems (NYSE: ADS) today announced they have signed a new, multi-year agreement for Alliance Data's Retail Services business to provide a cardless private label credit product for the Dwolla payment network. To read the full news, click here.

  Posted-In: Morgan Stanley US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

• [By Monica Gerson]

  Centene (NYSE: CNC) is estimated to report its Q3 earnings at $0.84 per share on revenue of $2.68 billion.

  FMC Technologies (NYSE: FTI) is projected to post its Q3 earnings at $0.59 per share on revenue of $1.75 billion.

• [By Holly LaFon]

  Importantly, we like the industry in which Centene (CNC) competes. Some of our investors might recall that one of our prior investments, Amerigroup, was acquired in 2012 by Wellpoint at a val uation that allowed us to achieve a return on investment of greater than 100% over the roughly one - year time period that we owned the shares. Medicaid managed care companies not only save states money but also offer better service; therefore, more states a re letting managed care companies run their Medicaid programs. To that end, states are expanding both the geographies carved out to managed care companies and the types of programs. The next phase of growth will come from the dual - eligible population. D uals (or dual - eligible population) are 8.3mm 3 people in the U.S. that are eligible to receive both Medicare and Medicaid benefits (mainly low - income seniors). According to the Kaiser Foundation, Duals accounted for almost 40% of Medicaid spending although they made up only 15% of the Medicaid population. We believe there are ample growth opportunities for CNC and other companies to meet the challenges of managing these disparate Medicaid members for the foreseeable future.

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Centene (NYSE: CNC  ) , whose recent revenue and earnings are plotted below.

Best International Stocks For 2015: Yamana Gold Inc.(AUY)

Yamana Gold Inc. engages in gold and other precious metals mining, and related activities, including exploration, extraction, processing, and reclamation. It also explores for copper, molybdenum, zinc, and silver metals. The company's portfolio includes 7 operating gold mines namely Chapada; El Pen Advisors' Opinion:

• [By Jim Jubak]

  I'll be doing exactly that kind of pruning and buying, in another week or so, with the two gold mining stocks, Goldcorp (GG) and Yamana Gold (AUY) that I own in my Jubak's Picks portfolio.

• [By Selena Maranjian]

  Yamana Gold (NYSE: AUY  ) fell 18%. It recently yielded 2%, and it has been upping that payout significantly. Bulls like its conservative management and relatively low costs, and have high hopes for its recently acquired Cerro Moro mine in Argentina.

• [By Ben Levisohn]

  Hamed singles out Goldcorp (GG) and Yamana Gold (AUY) as two companies that have strong production growth, falling costs, declining capital obligations and less debt than competitors. New Gold (NGD), meanwhile, should have the lowest all-on costs in the group at $731 an ounce, but its capital spending is likely to notes, Hamed says. Hamed rates Goldcorp and Yamana Overweight, while New Gold is rated Equal Weight.

• [By Sean Williams]

  Yamana Gold (NYSE: AUY  )
  Even if you're not the biggest fan of metal stocks, if you're going to add one to your Watchlist, make it Yamana Gold.

Best International Stocks For 2015: Equity Lifestyle Properties Inc. (ELS)

Equity LifeStyle Properties, Inc. is a publicly owned real estate investment trust (REIT). The firm engages in the ownership and operation of lifestyle oriented properties. Its portfolio of properties include various amenities and common facilities, such as a clubhouse, a swimming pool, laundry facilities, and cable television service, sauna/whirlpool spas, golf courses, tennis, shuffleboard and basketball courts, and exercise rooms. The firm leases developed sites to owners of manufactured homes referred to as resort homes, park models referred to as resort cottages, and recreational vehicles. It primarily invests in the markets of the United States. The firm primarily invests in land with lower maintenance costs and customer turnover costs, high quality real estate in and around major metropolitan areas, high barriers to entry, retirement and vacation destinations, growth markets, and appreciating component of real estate2. It was formerly known as Home Communities, Inc. The firm was founded in 1992 and is based in Chicago, Illinois with additional offices in Clearwater, Florida, Phoenix, Arizona, and Aurora, Colorado.

Advisors' Opinion:

• [By Rich Duprey]

  Real estate investment trust Equity Lifestyle Properties (NYSE: ELS  ) announced yesterday�that it's splitting its stock 2-for-1 on July 15 for holders of record on July 5.�

Best International Stocks For 2015: MedCAREERS Group Inc (MCGI)

MedCareers Group, Inc., incorporated on December 30, 2004, focus is to develop and build value through its wholly owned subsidiary Nurses Lounge (www.nurseslounge.com), an online professional network and communication source for nurses and organizations connected to the nursing community. On August 10, 2010, MedCareers acquired the workabroad.com Website from Steve Elisberg (Workabroad.com Website).

The Nurses Lounge is a professional network for nursing professionals providing relevant content and information and professional networking. Nurses can subscribe to Lounges created by nursing schools, nurse associations, employers, specialties and more to receive email updates of relevant news, events and other info. Professional networking is a place for nurses to connect with colleagues and network on a professional level.

Advisors' Opinion:

• [By Peter Graham]

  Last Friday, small cap stocks MedCAREERS Group Inc (OTCMKTS: MCGI), USmart Mobile Device Inc (OTCMKTS: UMDI) and Drinks Americas Holdings, Ltd (OTCMKTS: DKAM) were all over the place with the first two sinking 54% and 48.05%, respectively, while the last one rose 10.81%. It should be mentioned that all three small cap stocks have been the subject of paid promotions albeit none of these stocks have been over promoted. So where can investors and traders expect these stocks to head this week? Here is a quick look at what you might expect:

  MedCAREERS Group Inc (OTCMKTS: MCGI) Gets Additional Commitments to Join Its Subsidiary

  Small cap MedCAREERS Group aims to develop and build value through its wholly-owned subsidiary Nurses Lounge, Inc., an online professional network and communication source for nurses that offers a 21st century solution to recruitment and information that cannot be accomplished on a static nursing school or association website. On Friday, MedCAREERS Group sank 54% to $0.0575 for a market cap of $3.03 million plus MCGI is up 161.4% since the start of the year and down 93.9% over the past five years according to Google Finance.

• [By Peter Graham]

  While small cap green or renewable energy type of stocks have been the flavor of the month for many stock promoters (and sometimes still are), small cap health care stocks like PPJ Enterprise (OTCMKTS: PPJE), Plantation Development Corp (OTCMKTS: BRMA) and MedCAREERS Group Inc (OTCMKTS: MCGI) have also started to get some notice lately ��perhaps because Obamacare has been topping the news lately. However, are these small cap health care stocks a better bet for investors or for their promoters? Here is a quick reality check and a checkup: